Cargando…
Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733132/ https://www.ncbi.nlm.nih.gov/pubmed/36482446 http://dx.doi.org/10.1186/s12943-022-01692-9 |
| _version_ | 1784846295304765440 |
|---|---|
| author | Nuvoli, Barbara Germoni, Sabrina Morosetti, Carlotta Santoro, Raffaela Cortese, Giancarlo Masi, Serena Cordone, Iole Galati, Rossella |
| author_facet | Nuvoli, Barbara Germoni, Sabrina Morosetti, Carlotta Santoro, Raffaela Cortese, Giancarlo Masi, Serena Cordone, Iole Galati, Rossella |
| author_sort | Nuvoli, Barbara |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9733132 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97331322022-12-10 Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease Nuvoli, Barbara Germoni, Sabrina Morosetti, Carlotta Santoro, Raffaela Cortese, Giancarlo Masi, Serena Cordone, Iole Galati, Rossella Mol Cancer Retraction Note BioMed Central 2022-12-09 /pmc/articles/PMC9733132/ /pubmed/36482446 http://dx.doi.org/10.1186/s12943-022-01692-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Retraction Note Nuvoli, Barbara Germoni, Sabrina Morosetti, Carlotta Santoro, Raffaela Cortese, Giancarlo Masi, Serena Cordone, Iole Galati, Rossella Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease |
| title | Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease |
| title_full | Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease |
| title_fullStr | Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease |
| title_full_unstemmed | Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease |
| title_short | Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease |
| title_sort | retraction note: exemestane blocks mesothelioma growth through downregulation of camp, pcreb and cd44 implicating new treatment option in patients affected by this disease |
| topic | Retraction Note |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733132/ https://www.ncbi.nlm.nih.gov/pubmed/36482446 http://dx.doi.org/10.1186/s12943-022-01692-9 |
| work_keys_str_mv | AT nuvolibarbara retractionnoteexemestaneblocksmesotheliomagrowththroughdownregulationofcamppcrebandcd44implicatingnewtreatmentoptioninpatientsaffectedbythisdisease AT germonisabrina retractionnoteexemestaneblocksmesotheliomagrowththroughdownregulationofcamppcrebandcd44implicatingnewtreatmentoptioninpatientsaffectedbythisdisease AT morosetticarlotta retractionnoteexemestaneblocksmesotheliomagrowththroughdownregulationofcamppcrebandcd44implicatingnewtreatmentoptioninpatientsaffectedbythisdisease AT santororaffaela retractionnoteexemestaneblocksmesotheliomagrowththroughdownregulationofcamppcrebandcd44implicatingnewtreatmentoptioninpatientsaffectedbythisdisease AT cortesegiancarlo retractionnoteexemestaneblocksmesotheliomagrowththroughdownregulationofcamppcrebandcd44implicatingnewtreatmentoptioninpatientsaffectedbythisdisease AT masiserena retractionnoteexemestaneblocksmesotheliomagrowththroughdownregulationofcamppcrebandcd44implicatingnewtreatmentoptioninpatientsaffectedbythisdisease AT cordoneiole retractionnoteexemestaneblocksmesotheliomagrowththroughdownregulationofcamppcrebandcd44implicatingnewtreatmentoptioninpatientsaffectedbythisdisease AT galatirossella retractionnoteexemestaneblocksmesotheliomagrowththroughdownregulationofcamppcrebandcd44implicatingnewtreatmentoptioninpatientsaffectedbythisdisease |